The European Medicines Agency (EMA) on Wednesday gave the green light to the vaccine from the American laboratory Moderna against the coronavirus, the second vaccine against Covid-19 to which it gives its approval for use in the European Union.
"The EMA has recommended granting conditional marketing authorization for Moderna's Covid-19 vaccine to prevent disease in people over the age of 18," according to a statement from the European authority Regulatory Authority for Medicines, based in Amsterdam.
This vaccine has already received, on December 18, emergency authorization from the United States Medicines Agency (FDA), a week after doing the same with that of Pfizer-BioNTech.
Canada followed the United States on December 23.
The future American Vice-President Kamala Harris received the first of two doses of the Moderna vaccine at the end of December, calling on all Americans to also be vaccinated.
With AFP
The summary of the week
France 24 invites you to come back to the news that marked the week
I subscribe
Take international news everywhere with you!
Download the France 24 application
google-play-badge_FR